Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare time to progression between the combination
pemetrexed-carboplatin and pemetrexed alone in previously treated patients with locally
advanced or metastatic NSCLC.